$AMED
AMEDISYS INC

2014 Q1 Form 10-Q Financial Statement

#000119312514189360 Filed on May 08, 2014

View on sec.gov

Income Statement

Concept 2014 Q1 2013 Q4 2013 Q1
Revenue $298.7M $302.2M $328.6M
YoY Change -9.1% -13.71% -7.7%
Cost Of Revenue $177.0M $178.4M $185.7M
YoY Change -4.66% -9.81% -10.95%
Gross Profit $121.7M $123.8M $142.9M
YoY Change -14.84% -18.77% -8.92%
Gross Profit Margin 40.74% 40.97% 43.49%
Selling, General & Admin $121.3M $119.6M $127.6M
YoY Change -4.94% -10.81% -4.85%
% of Gross Profit 99.67% 96.61% 89.29%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $7.936M $8.700M $10.12M
YoY Change -21.6% -13.86% -0.42%
% of Gross Profit 6.52% 7.03% 7.08%
Operating Expenses $129.2M $124.4M $137.5M
YoY Change -6.04% -13.55% -4.38%
Operating Profit -$19.57M -$600.0K $5.367M
YoY Change -464.69% -107.06% -56.92%
Interest Expense $1.261M -$1.400M $1.092M
YoY Change 15.48% -74.07% -47.35%
% of Operating Profit 20.35%
Other Income/Expense, Net -$278.0K -$1.000M -$659.0K
YoY Change -57.81% -127.78% -50.26%
Pretax Income -$19.85M -$14.30M $4.708M
YoY Change -521.64% -90.8% -57.71%
Income Tax -$7.618M -$5.300M $1.851M
% Of Pretax Income 39.32%
Net Earnings -$12.40M -$9.600M $2.700M
YoY Change -559.26% -91.01% -50.0%
Net Earnings / Revenue -4.15% -3.18% 0.82%
Basic Earnings Per Share -$0.39 -$0.30 $0.09
Diluted Earnings Per Share -$0.39 -$0.30 $0.09
COMMON SHARES
Basic Shares Outstanding 31.86M shares 32.46M shares 30.64M shares
Diluted Shares Outstanding 31.86M shares 31.10M shares

Balance Sheet

Concept 2014 Q1 2013 Q4 2013 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $2.800M $17.30M $7.000M
YoY Change -60.0% 19.31% -83.05%
Cash & Equivalents $2.840M $17.30M $7.021M
Short-Term Investments
Other Short-Term Assets $85.40M $10.79M $30.70M
YoY Change 178.18% -5.73% -12.03%
Inventory
Prepaid Expenses $10.67M
Receivables $115.4M $111.1M $144.7M
Other Receivables $0.00 $5.700M $0.00
Total Short-Term Assets $203.5M $205.3M $182.4M
YoY Change 11.57% -0.25% -23.36%
LONG-TERM ASSETS
Property, Plant & Equipment $157.0M $159.0M $156.5M
YoY Change 0.35% 1.48% 8.67%
Goodwill $208.9M $208.9M $210.0M
YoY Change -0.51% -0.33%
Intangibles $34.34M $36.70M $46.79M
YoY Change -26.62% -21.91%
Long-Term Investments $23.20M
YoY Change
Other Assets $27.59M $26.28M $24.86M
YoY Change 11.0% 40.93% -72.2%
Total Long-Term Assets $523.9M $521.1M $529.9M
YoY Change -1.14% -0.7% -14.17%
TOTAL ASSETS
Total Short-Term Assets $203.5M $205.3M $182.4M
Total Long-Term Assets $523.9M $521.1M $529.9M
Total Assets $727.4M $726.4M $712.3M
YoY Change 2.12% -0.57% -16.73%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $24.20M $20.14M $27.65M
YoY Change -12.47% -30.97% 34.86%
Accrued Expenses $61.50M $57.57M $57.05M
YoY Change 7.79% 4.95% -62.76%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $13.00M $13.90M $35.80M
YoY Change -63.69% -61.18% -47.74%
Total Short-Term Liabilities $324.7M $312.4M $202.8M
YoY Change 60.1% 52.56% -19.64%
LONG-TERM LIABILITIES
Long-Term Debt $30.00M $33.00M $43.00M
YoY Change -30.23% -50.67% -37.13%
Other Long-Term Liabilities $9.761M $8.511M $4.761M
YoY Change 105.02% 82.21% 3.5%
Total Long-Term Liabilities $39.76M $41.51M $47.76M
YoY Change -16.75% -42.0% -34.57%
TOTAL LIABILITIES
Total Short-Term Liabilities $324.7M $312.4M $202.8M
Total Long-Term Liabilities $39.76M $41.51M $47.76M
Total Liabilities $364.5M $353.9M $250.5M
YoY Change 45.48% 28.07% -23.31%
SHAREHOLDERS EQUITY
Retained Earnings -$89.98M -$77.56M $21.30M
YoY Change -522.51% -516.61%
Common Stock $470.9M $467.9M $456.0M
YoY Change 3.25% 3.79%
Preferred Stock
YoY Change
Treasury Stock (at cost) $18.19M $18.18M $17.12M
YoY Change 6.26% 6.19%
Treasury Stock Shares 875.9K shares 875.0K shares 790.2K shares
Shareholders Equity $362.7M $372.2M $460.3M
YoY Change
Total Liabilities & Shareholders Equity $727.4M $726.4M $712.3M
YoY Change 2.12% -0.57% -16.73%

Cashflow Statement

Concept 2014 Q1 2013 Q4 2013 Q1
OPERATING ACTIVITIES
Net Income -$12.40M -$9.600M $2.700M
YoY Change -559.26% -91.01% -50.0%
Depreciation, Depletion And Amortization $7.936M $8.700M $10.12M
YoY Change -21.6% -13.86% -0.42%
Cash From Operating Activities -$6.342M $8.400M $32.42M
YoY Change -119.56% -46.15% 196.66%
INVESTING ACTIVITIES
Capital Expenditures $5.532M -$12.70M $10.07M
YoY Change -45.09% -21.12% -1.58%
Acquisitions $0.00 $627.0K
YoY Change -100.0%
Other Investing Activities $600.0K $1.800M -$6.800M
YoY Change -108.82% -150.0% -3500.0%
Cash From Investing Activities -$4.920M -$11.00M -$16.83M
YoY Change -70.76% -44.44% 67.36%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net $3.952M $23.95M
YoY Change -83.5% 180.14%
Cash From Financing Activities -3.201M -23.70M -23.12M
YoY Change -86.15% 15.61% 204.63%
NET CHANGE
Cash From Operating Activities -6.342M 8.400M 32.42M
Cash From Investing Activities -4.920M -11.00M -16.83M
Cash From Financing Activities -3.201M -23.70M -23.12M
Net Change In Cash -14.46M -26.30M -7.524M
YoY Change 92.22% 6.48% 12.06%
FREE CASH FLOW
Cash From Operating Activities -$6.342M $8.400M $32.42M
Capital Expenditures $5.532M -$12.70M $10.07M
Free Cash Flow -$11.87M $21.10M $22.34M
YoY Change -153.15% -33.44% 3133.29%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2014Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
727390000
CY2014Q1 us-gaap Assets
Assets
727390000
CY2013Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
70801000
CY2014Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
787000
CY2014Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
190000
CY2014Q1 us-gaap Deferred Tax Liabilities Current
DeferredTaxLiabilitiesCurrent
0
CY2014Q1 us-gaap Liabilities Current
LiabilitiesCurrent
324714000
CY2014Q1 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
30000000
CY2014Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
9761000
CY2014Q1 us-gaap Liabilities
Liabilities
364475000
CY2013Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
57572000
CY2013Q4 us-gaap Deferred Tax Liabilities Current
DeferredTaxLiabilitiesCurrent
0
CY2013Q4 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
33000000
CY2013Q4 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
13904000
CY2013Q4 us-gaap Liabilities
Liabilities
353927000
CY2013Q4 us-gaap Liabilities Current
LiabilitiesCurrent
312416000
CY2013Q4 us-gaap Preferred Stock Value Outstanding
PreferredStockValueOutstanding
0
CY2014Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
76066000
CY2014Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
61498000
CY2014Q1 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
12952000
CY2013Q4 us-gaap Goodwill
Goodwill
208915000
CY2013Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
36690000
CY2014Q1 us-gaap Goodwill
Goodwill
208923000
CY2014Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
34336000
CY2014Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
27589000
CY2014Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2013Q4 us-gaap Assets
Assets
726406000
CY2013Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
26283000
CY2014Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-89978000
CY2013Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
8511000
CY2013Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-546000
CY2013Q1 us-gaap Net Income Loss
NetIncomeLoss
2679000
CY2013Q1 us-gaap Profit Loss
ProfitLoss
2133000
CY2014Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
3491000
CY2014Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
9591000
CY2014Q1 us-gaap Labor And Related Expense
LaborAndRelatedExpense
83171000
CY2013Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
363000
CY2014Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
362915000
CY2013Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
59000
CY2014Q1 us-gaap Pension Expense
PensionExpense
1392000
CY2013Q1 us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
12500000
CY2014Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
14131000
CY2013Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-23115000
CY2013Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
5367000
CY2013Q1 us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
11000
CY2014Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2014Q1 us-gaap Share Based Compensation
ShareBasedCompensation
431000
CY2014Q1 amed Accrued Charge Related To Us Department Of Justice Settlement
AccruedChargeRelatedToUsDepartmentOfJusticeSettlement
150000000
CY2014Q1 us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
6000
CY2014Q1 us-gaap Interest Expense
InterestExpense
1261000
CY2014Q1 us-gaap Profit Loss
ProfitLoss
-12510000
CY2014Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-93000
CY2014Q1 us-gaap Net Income Loss
NetIncomeLoss
-12417000
CY2014Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
24198000
CY2013Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
32538971 shares
CY2013Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2014Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
32608356 shares
CY2014Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2013Q4 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
33000
CY2013Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
467890000
CY2013Q4 us-gaap Treasury Stock Value
TreasuryStockValue
18176000
CY2013Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
15000
CY2013Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-77561000
CY2013Q4 us-gaap Stockholders Equity
StockholdersEquity
372201000
CY2013Q4 us-gaap Minority Interest
MinorityInterest
278000
CY2013Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
372479000
CY2013Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
726406000
CY2014Q1 us-gaap Stockholders Equity
StockholdersEquity
362730000
CY2014Q1 us-gaap Minority Interest
MinorityInterest
185000
CY2014Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
470851000
CY2014Q1 us-gaap Treasury Stock Value
TreasuryStockValue
18191000
CY2014Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
15000
CY2014Q1 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
33000
CY2014Q1 us-gaap Preferred Stock Value Outstanding
PreferredStockValueOutstanding
0
CY2014Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0
CY2013Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0
CY2013Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
25133000
CY2013Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
14231000
CY2013Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
129891000
CY2013Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2013Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2013Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
874999 shares
CY2013Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
33413970 shares
CY2013Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2013Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
60000000 shares
CY2013Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2014Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
137022000
CY2014Q1 us-gaap Treasury Stock Shares
TreasuryStockShares
875862 shares
CY2014Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
25279000
CY2014Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2014Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2014Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
33484218 shares
CY2014Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
60000000 shares
CY2013Q4 us-gaap Assets Held For Sale At Carrying Value
AssetsHeldForSaleAtCarryingValue
60000
CY2014Q1 us-gaap Assets Held For Sale At Carrying Value
AssetsHeldForSaleAtCarryingValue
18000
CY2014Q1 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
57325000
CY2013Q4 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
55329000
CY2013Q4 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
90214000
CY2014Q1 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
95991000
CY2013Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
159025000
CY2014Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
157034000
CY2014Q1 us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
42698000
CY2014Q1 us-gaap Costs And Expenses
CostsAndExpenses
318312000
CY2014Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-19573000
CY2014Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-278000
CY2014Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-19851000
CY2014Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-7618000
CY2014Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-277000
CY2014Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.39
CY2014Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.39
CY2013Q1 us-gaap Health Care Organization Patient Service Revenue
HealthCareOrganizationPatientServiceRevenue
328602000
CY2013Q1 us-gaap Cost Of Services
CostOfServices
185667000
CY2013Q1 us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
41848000
CY2013Q1 us-gaap Labor And Related Expense
LaborAndRelatedExpense
79840000
CY2013Q1 us-gaap Costs And Expenses
CostsAndExpenses
323235000
CY2013Q1 us-gaap Share Based Compensation
ShareBasedCompensation
2056000
CY2013Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
4708000
CY2013Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-659000
CY2013Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1851000
CY2013Q1 us-gaap Interest Expense
InterestExpense
1092000
CY2013Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.09
CY2013Q1 amed Provision For Doubtful Accounts For Continuing Operations
ProvisionForDoubtfulAccountsForContinuingOperations
3854000
CY2013Q1 amed Depreciation And Amortization For Continuing Operations
DepreciationAndAmortizationForContinuingOperations
9970000
CY2013Q1 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.11
CY2013Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
-0.02
CY2013Q1 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.11
CY2014Q1 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.38
CY2014Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
-0.01
CY2014Q1 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.38
CY2013Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-724000
CY2013Q1 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
2857000
CY2014Q1 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-12233000
CY2014Q1 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-12140000
CY2013Q1 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
3403000
CY2013Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
-724000
CY2014Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
-277000
CY2014Q1 us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
2208000
CY2013Q1 us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
0
CY2014Q1 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-332000
CY2014Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-7799000
CY2014Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
141000
CY2014Q1 us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
400000
CY2014Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
9185000
CY2014Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
6337000
CY2014Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
1219000
CY2014Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-6342000
CY2014Q1 us-gaap Proceeds From Sale Of Restricted Investments
ProceedsFromSaleOfRestrictedInvestments
0
CY2014Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
5532000
CY2014Q1 us-gaap Payments To Acquire Restricted Investments
PaymentsToAcquireRestrictedInvestments
33000
CY2014Q1 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0
CY2014Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-4920000
CY2014Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
89000
CY2014Q1 us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
657000
CY2014Q1 us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
5000
CY2013Q1 us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
0
CY2013Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-945000
CY2013Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
1990000
CY2013Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
10074000
CY2013Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
32416000
CY2013Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0
CY2013Q1 us-gaap Proceeds From Sale Of Restricted Investments
ProceedsFromSaleOfRestrictedInvestments
71000
CY2013Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
8420000
CY2013Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
7021000
CY2013Q1 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
627000
CY2013Q1 us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
837000
CY2013Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
23952000
CY2013Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-7524000
CY2013Q1 us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
400000
CY2013Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-20545000
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
14545000
CY2014Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
4968000
CY2013Q1 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
61000
CY2014Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
7936000
CY2014Q1 us-gaap Payments For Proceeds From Investments
PaymentsForProceedsFromInvestments
0
CY2014Q1 us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
54000000
CY2014Q1 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
1250000
CY2014Q1 us-gaap Noncontrolling Interest Increase From Business Combination
NoncontrollingInterestIncreaseFromBusinessCombination
0
CY2013Q1 us-gaap Proceeds From Divestiture Of Businesses
ProceedsFromDivestitureOfBusinesses
0
CY2014Q1 us-gaap Proceeds From Divestiture Of Businesses
ProceedsFromDivestitureOfBusinesses
645000
CY2014Q1 us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
54000000
CY2013Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-16825000
CY2014Q1 us-gaap Gains Losses On Sales Of Assets
GainsLossesOnSalesOfAssets
645000
CY2013Q1 us-gaap Gains Losses On Sales Of Assets
GainsLossesOnSalesOfAssets
0
CY2014Q1 us-gaap Disposal Group Including Discontinued Operation Revenue
DisposalGroupIncludingDiscontinuedOperationRevenue
-300000
CY2013Q1 us-gaap Discontinued Operation Tax Effect Of Discontinued Operation
DiscontinuedOperationTaxEffectOfDiscontinuedOperation
-500000
CY2014Q1 amed Minimum Percent Ownership For Controlling Interest Percent
MinimumPercentOwnershipForControllingInterestPercent
0.5 pure
CY2014Q1 us-gaap Use Of Estimates
UseOfEstimates
<p style='margin-top:6pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;font-style:italic;margin-left:0px;">Use of Estimates </font></p><p style='margin-top:4.5pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;">Our accounting and reporting policies conform with U.S.</font><font style="font-family:Times New Roman;font-size:10pt;"> </font><font style="font-family:Times New Roman;font-size:10pt;">G</font><font style="font-family:Times New Roman;font-size:10pt;">AAP. In preparing the </font><font style="font-family:Times New Roman;font-size:10pt;">unaudited condensed </font><font style="font-family:Times New Roman;font-size:10pt;">consolidated financial statements, we are required to make estimates and assumptions that impact the amounts reported in the</font><font style="font-family:Times New Roman;font-size:10pt;"> condensed</font><font style="font-family:Times New Roman;font-size:10pt;"> consolidated financial statements and accompanying notes. Actual results could materially differ from those estimates. </font></p>
CY2014Q1 amed Percentage Of Total Reimbursement Of Outlier Payment
PercentageOfTotalReimbursementOfOutlierPayment
0.1 pure
CY2014Q1 amed Maximum Percent Ownership For Equity Method Percent
MaximumPercentOwnershipForEquityMethodPercent
0.5 pure
CY2014Q1 amed Maximum Percent Ownership For Cost Method Percent
MaximumPercentOwnershipForCostMethodPercent
0.2 pure
CY2014Q1 us-gaap Comparability Of Prior Year Financial Data
ComparabilityOfPriorYearFinancialData
<p style='margin-top:6pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;font-style:italic;margin-left:0px;">Reclassifications </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;font-style:italic;">and Comparability </font></p><p style='margin-top:4.5pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;">Certain reclassifications have been made to prior period's financial statements in order to conform to the current period's presentation</font><font style="font-family:Times New Roman;font-size:10pt;">.</font></p><p style='margin-top:6pt; margin-bottom:0pt'>&#160;</p>
CY2014Q1 us-gaap Number Of States In Which Entity Operates
NumberOfStatesInWhichEntityOperates
37 States
CY2014Q1 us-gaap Concentration Risk Percentage1
ConcentrationRiskPercentage1
0.83 pure
CY2013Q1 us-gaap Concentration Risk Percentage1
ConcentrationRiskPercentage1
0.84 pure
CY2013Q4 us-gaap Cost Method Investments
CostMethodInvestments
5000000
CY2013Q4 us-gaap Equity Method Investment Aggregate Cost
EquityMethodInvestmentAggregateCost
11900000
CY2014Q1 us-gaap Equity Method Investment Aggregate Cost
EquityMethodInvestmentAggregateCost
13700000
CY2014Q1 us-gaap Cost Method Investments
CostMethodInvestments
5000000
CY2014Q1 amed Episode Of Care As Episodic Based Revenue
EpisodeOfCareAsEpisodicBasedRevenue
60
CY2014Q1 amed Historical Collection Rate From Medicare
HistoricalCollectionRateFromMedicare
0.99 pure
CY2014Q1 amed Episodes In Progress That Begin During Reporting Period
EpisodesInProgressThatBeginDuringReportingPeriod
60
CY2014Q1 amed First Threshold Of Therapy Services Required
FirstThresholdOfTherapyServicesRequired
6 Number_of_Visits
CY2014Q1 amed Low Utilization Payment Adjustment Number Of Visits
LowUtilizationPaymentAdjustmentNumberOfVisits
5 Number_of_Visits
CY2014Q1 amed Hospice Medicare Revenue Rate Accounted For Routine Care
HospiceMedicareRevenueRateAccountedForRoutineCare
0.99 pure
CY2014Q1 amed Revenue Adjustment To Medicare Revenue
RevenueAdjustmentToMedicareRevenue
1200000
CY2014Q1 amed Second Threshold Of Services Required
SecondThresholdOfServicesRequired
14 Number_of_Visits
CY2014Q1 amed Third Threshold Of Therapy Services Required
ThirdThresholdOfTherapyServicesRequired
20 Number_of_Visits
CY2014Q1 amed Maximum Days To Submit Final Bill From Date Request For Anticipated Payment Was Paid
MaximumDaysToSubmitFinalBillFromDateRequestForAnticipatedPaymentWasPaid
60
CY2014Q1 amed Portion Of Patient Accounts Receivable Derived From Medicare
PortionOfPatientAccountsReceivableDerivedFromMedicare
0.67 pure
CY2013 amed Portion Of Patient Accounts Receivable Derived From Medicare
PortionOfPatientAccountsReceivableDerivedFromMedicare
0.67 pure
CY2013Q1 amed Hospice Medicare Revenue Rate Accounted For Routine Care
HospiceMedicareRevenueRateAccountedForRoutineCare
0.99 pure
CY2013Q1 amed Revenue Adjustment To Medicare Revenue
RevenueAdjustmentToMedicareRevenue
3800000
CY2014Q1 amed Minimum Days Accounts Receivable Outstanding Fully Reserved
MinimumDaysAccountsReceivableOutstandingFullyReserved
365
CY2014Q1 amed Rate Of Request For Anticipated Payment Submitted For Initial Episode Of Care
RateOfRequestForAnticipatedPaymentSubmittedForInitialEpisodeOfCare
0.6 pure
CY2014Q1 amed Rate Of Request For Anticipated Payment Submitted For Subsequent Episodes Of Care
RateOfRequestForAnticipatedPaymentSubmittedForSubsequentEpisodesOfCare
0.5 pure
CY2014Q1 amed Maximum Days To Submit Final Bill From Start Of Episode
MaximumDaysToSubmitFinalBillFromStartOfEpisode
120
CY2014Q1 amed Percentage Of Patient Receivables Outstanding
PercentageOfPatientReceivablesOutstanding
0.1 pure
CY2014Q1 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
43000000
CY2014Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
31864000 shares
CY2014Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
CY2014Q1 amed Non Vested Stock And Stock Units
NonVestedStockAndStockUnits
0 shares
CY2014Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
31864000 shares
CY2014Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
772000 shares
CY2013Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
220000 shares
CY2013Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
21000 shares
CY2013Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
30640000 shares
CY2013Q1 amed Non Vested Stock And Stock Units
NonVestedStockAndStockUnits
443000 shares
CY2013Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
31104000 shares
CY2014Q1 us-gaap Discontinued Operation Income Loss From Discontinued Operation Before Income Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax
-500000
CY2014Q1 us-gaap Discontinued Operation Tax Effect Of Discontinued Operation
DiscontinuedOperationTaxEffectOfDiscontinuedOperation
-200000
CY2013Q1 us-gaap Disposal Group Including Discontinued Operation Revenue
DisposalGroupIncludingDiscontinuedOperationRevenue
10600000
CY2013Q1 us-gaap Discontinued Operation Income Loss From Discontinued Operation Before Income Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax
-1200000
CY2013 amed Number Of Care Centers Available For Sale
NumberOfCareCentersAvailableForSale
28 Agencies
CY2014Q1 amed Final Payment Of Us Department Of Justice Settlement
FinalPaymentOfUsDepartmentOfJusticeSettlement
35000000
amed Payment Upon Execution Of Us Department Of Justice Settlement
PaymentUponExecutionOfUsDepartmentOfJusticeSettlement
116500000
CY2014Q1 amed Relators Attorneys Fees For Us Department Of Justice Settlement
RelatorsAttorneysFeesForUsDepartmentOfJusticeSettlement
3900000
CY2014Q1 us-gaap Long Term Debt
LongTermDebt
43000000
CY2013Q4 us-gaap Long Term Debt
LongTermDebt
46900000
CY2014Q1 amed Fixed Charge Coverage Ratio
FixedChargeCoverageRatio
1.4 pure
CY2014Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
30000000
CY2013Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
33000000
CY2014Q1 amed Total Leverage Ratio
TotalLeverageRatio
3.2 pure
CY2014Q1 amed Health Insurance Retention Limit
HealthInsuranceRetentionLimit
900000
CY2014Q1 amed Professional Liability Insurance Retention Limit
ProfessionalLiabilityInsuranceRetentionLimit
300000
CY2014Q1 amed Workers Compensation Insurance Retention Limit
WorkersCompensationInsuranceRetentionLimit
500000
amed Medicare Revenue
MedicareRevenue
4000000
CY2014Q1 amed Payment Upon Execution Of Us Department Of Justice Settlement
PaymentUponExecutionOfUsDepartmentOfJusticeSettlement
115000000
CY2014Q1 amed General And Administrative Expense Segment
GeneralAndAdministrativeExpenseSegment
126300000
CY2013Q1 amed General And Administrative Expense Segment
GeneralAndAdministrativeExpenseSegment
123700000
us-gaap Proceeds From Divestiture Of Businesses
ProceedsFromDivestitureOfBusinesses
6000000

Files In Submission

Name View Source Status
0001193125-14-189360-index-headers.html Edgar Link pending
0001193125-14-189360-index.html Edgar Link pending
0001193125-14-189360.txt Edgar Link pending
0001193125-14-189360-xbrl.zip Edgar Link pending
amed-20140331.xml Edgar Link completed
amed-20140331.xsd Edgar Link pending
amed-20140331_cal.xml Edgar Link unprocessable
amed-20140331_def.xml Edgar Link unprocessable
amed-20140331_lab.xml Edgar Link unprocessable
amed-20140331_pre.xml Edgar Link unprocessable
d722333d10q.htm Edgar Link pending
d722333dex101.htm Edgar Link pending
d722333dex103.htm Edgar Link pending
d722333dex311.htm Edgar Link pending
d722333dex312.htm Edgar Link pending
d722333dex321.htm Edgar Link pending
d722333dex322.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
g722333g33e41.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending